BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 31539777)

  • 1. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
    Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Sharma V; Angeli A; Kumar R; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Apr; 150():678-686. PubMed ID: 29571155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.
    Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors.
    Kumar A; Siwach K; Rom T; Kumar R; Angeli A; Kumar Paul A; Supuran CT; Sharma PK
    Bioorg Chem; 2022 Jun; 123():105764. PubMed ID: 35366582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
    Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
    Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-1,2,3-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis, crystal structure, computational studies and inhibitory activity against carbonic anhydrase I, II, and IX isoforms†.
    Aimene Y; Eychenne R; Mallet-Ladeira S; Saffon N; Winum JY; Nocentini A; Supuran CT; Benoist E; Seridi A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):773-782. PubMed ID: 30843736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
    Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
    Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
    Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors.
    Swain B; Angeli A; Angapelly S; Thacker PS; Singh P; Supuran CT; Arifuddin M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1199-1209. PubMed ID: 31237458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives.
    Bozdag M; Bua S; Osman SM; AlOthman Z; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):885-892. PubMed ID: 28644059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors.
    Lolak N; Akocak S; Bua S; Koca M; Supuran CT
    Bioorg Chem; 2018 Apr; 77():542-547. PubMed ID: 29462772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors.
    Mahmood SU; Saeed A; Bua S; Nocentini A; Gratteri P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():381-386. PubMed ID: 29421714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
    Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
    Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.